Gossamer Bio, Inc.
GOSS
$1.45
$0.1511.54%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -30.80M | 49.23M | -41.93M | -48.15M | -40.01M |
| Total Depreciation and Amortization | 1.10M | 992.00K | 986.00K | 1.01M | 1.09M |
| Total Amortization of Deferred Charges | 234.00K | 321.00K | 293.00K | 308.00K | 323.00K |
| Total Other Non-Cash Items | 1.49M | 2.01M | 3.08M | 12.45M | 4.03M |
| Change in Net Operating Assets | -4.05M | 63.80M | -14.73M | 960.00K | 77.00K |
| Cash from Operations | -32.03M | 116.35M | -52.30M | -33.42M | -34.49M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -26.75M | -59.11M | 61.67M | -14.37M | -118.26M |
| Cash from Investing | -26.75M | -59.11M | 61.67M | -14.37M | -118.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -9.68M | -2.90M | -2.90M | -2.90M |
| Issuance of Common Stock | 281.00K | 0.00 | 348.00K | 0.00 | 201.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 464.00K | -- | -- | -- |
| Cash from Financing | 281.00K | -9.21M | -2.56M | -2.90M | 198.50M |
| Foreign Exchange rate Adjustments | 93.00K | -8.00K | -62.00K | 193.00K | -136.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -58.41M | 48.01M | 6.75M | -50.50M | 45.61M |
